Bausch Health Companies | VRX - Net Income

Stock Price
7.90
Daily Change
0.13 1.67%
Monthly
-22.62%
Yearly
-25.05%
Q1 Forecast
7.62

Bausch Health Companies reported $179M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Amgen USD 1.33B 1.88B Dec/2025
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bausch Health Companies USD 179M 31M Sep/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 2.2B 891M Sep/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Gilead Sciences USD 3.05B 1.09B Sep/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Prestige Brands USD 69.13M 7.36M Sep/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Vertex Pharmaceuticals USD 1.08B 50M Sep/2025
Zoetis USD 721M 3M Sep/2025